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Edited by Judit OvadiAbstract Previously, two diﬀerent carrier systems for uptake of
reduced folates and the antifolate methotrexate (Mtx) were
described: the pH-dependent folate sensitive reduced folate
carrier 1 (RFC1) from human, hamster and mouse and a
sodium-dependent and folate insensitive Mtx carrier-1 (MTX-1)
from rat. It was found that all critical residues of the homologous
amino acid sequence were identical. RFC1- as well as MTX-
1-mediated uptake of a marker substrate into suitable human
and rat cell lines increased with proton concentration, was
sodium-dependent at neutral pH, and inhibited by folate at acidic
pH. It is concluded that RFC1 and MTX-1 are orthologs.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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It has long been established, that the uptake of hydrophilic
antifolates like methotrexate (Mtx) and reduced folates in-
cluding tetrahydrofolate and 5-formyltetrahydrofolate into
mammalian cells is mediated by an active (reduced folate)
carrier system [1]. Changes in the reduced folate transport
capacity were linked to antifolate resistance in tumor therapy
[2]. In 1994, the isolation of a cDNA coding for the reduced
folate carrier protein (RFC1) from mouse and hamster by
expression cloning in a transport deﬁcient cancer cell line was
reported [3,4]. The authors utilized the increased resistance
against the lipophilic antifolate trimetrexate that was conferred
by RFC1 mediating the cellular uptake of antagonistic 5-for-
myltetrahydrofolate or the ability to grow in low (2 nM) folinic
acid medium as selection marker. Using this sequence as
probe, the human homolog (hRFC1) was isolated from a
cDNA library [5,6]. In the course of its functional character-
ization, it was found that RFC1 function may be modulated by
the tissue environment. While a pH optimum around 7.5 was
reported in the L1210 leukemia cells [7], reduced folates and
Mtx were more eﬃciently transported at acidic pH in liver and
intestinal cells, and this transport was inhibited by folic acid* Corresponding author. Fax: +49-341-9738149.
E-mail address: honscha@vetmed.uni-leipzig.de (W. Honscha).
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doi:10.1016/j.febslet.2004.04.010(FA) at pH 5.5 but not pH 7.4 [8,9]. Sodium dependency of
RFC1 was until now not shown.
In rat, a similar carrier system for Mtx with sensitivity to
reduced folates was demonstrated and cloned [10,11]. The
activity of this transporter was described as strictly sodium-
dependent when examined in freshly isolated hepatocytes,
where it accounts for 90% of the Mtx uptake, as well as after
heterologous expression. It was therefore termed as the rat
sodium-dependent Mtx carrier-1 (MTX-1). So far, there are no
reports on the pH/proton dependency of this protein. Further,
there is apparently no inhibition of transport by FA, at least at
neutral pH [10,12]. This is in contrast to the observations made
with human and mouse RFC1, which are inhibited by FA, at
least at acidic pH.
Therefore, we systematically compared the sequences of
human and mouse RFC1 with rat MTX-1 giving special con-
sideration to amino acids that have been linked to substrate
binding or transport. Furthermore, a human and a rat cell line
expressing high levels of RFC1 or MTX-1 activity, respec-
tively, were analyzed with regard to inﬂuence of pH, sodium
dependency and inhibition by FA at acidic pH.2. Materials and methods
All chemicals including media and supplements were obtained from
Sigma–Aldrich (Deisenhofen, Germany) unless stated otherwise.
2.1. Cell culture and uptake experiments
The human adenocarcinoma cell line Caco-2 was purchased from
ATCC (Rockville, MD) and the rat hepatocytoma cell line HPCT-1E3
was donated by E. Petzinger (Institute of Pharmacology and Toxi-
cology, Justus-Liebig-University Giessen, Germany). Caco-2 cultures
were grown in DMEM containing 10% FCS (Greiner, Frickenhausen,
Germany), 2 mM glutamine and 1 non-essential amino acids, while
HPCT-1E3 medium was further supplemented with 10 lg/ml insulin,
10 lg/ml inosin and 1.5 lM dexamethasone. Upon conﬂuency, the cells
were sub-cultured using trypsin/EDTA for detachment.
For uptake studies, freshly trypsinized cells were seeded onto 96 well
plates at a density of 150 000 (Caco-2) or 45 000 (HPCT-1E3) cells/cm2
and grown until cells displayed a diﬀerentiated phenotype after 5
(Caco-2) or 3 (HPCT-1E3) days. The medium was replaced for a 15
min equilibration period with Tyrode salt solution (137 mM NaCl, 3
mMKCl, 1 mMMgCl2, 2 mM CaCl2 and 5.5 mM glucose) or sodium-
free Choline-Tyrode salt solution (137 mM choline chloride, 3 mM
KCl, 1 mMMgCl2, 2 mM CaCl2 and 5.5 mM glucose) buﬀered with 20
mMMES (pH 5.0–6.5) or 20 mM HEPES (pH 7.0–8.0). The transport
substrate ﬂuorescein-methotrexate (FMTX, Molecular Probes, Eu-
gene, NL) was added at a concentration of 10 lM and uptake was
allowed for 30 min at 37 C. Linearity was shown in a preliminary
experiment over 5, 10, 20, 30 and 60 min. Incubation was stopped by
transfer onto ice and two washing steps with ice-cold PBS. Finally,blished by Elsevier B.V. All rights reserved.
Table 1
Amino acid sequence similarity of human RFC1, rat MTX-1 and
mouse and hamster RFC1
[% identity] Human
RFC1
Rat
MTX-1
Mouse
RFC1
Hamster
RFC1
Human RFC1 66.7 67.3 66.1
Rat MTX-1 90.0 83.6
Mouse RFC1 80.6
Hamster RFC1
A multiple sequence alignment according to the Hein method was
performed using DNAStar. Sequence similarity is expressed pairwise
as percentage of identical residues.
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suitable microplate reader. The buﬀering capacity of the washing and
lysis solutions did compensate pH eﬀects of the incubation and avoi-
ded artifacts due to the pH dependency of FMTX ﬂuorescence. FMTX
uptake over 30 min was expressed as picomoles per well using a
standard.
For inhibition studies, FA was added at various concentrations to
the equilibration as well as the incubation buﬀer.
2.2. Sequence analysis
Amino acid sequences for human RFC1, rat MTX-1, mouse and
hamster RFC1 were obtained from NCBI. A multiple sequence
alignment was performed using DNAStar MegAlign v5.06 (DNAStar
Inc., Madison, WI) according to the method of Hein [13] with a gap
penalty of 11, a gap length penalty of 3, a Ktuple of 2 and residue
weighting according to the PAM250 table. Sequence similarity was
expressed pairwise as percentage of identical residues.
2.3. Statistical analysis
Uptake activities are given as meansSD of at least six replicate
measurements. The signiﬁcance of the results was determined using the
F-test. Statistical signiﬁcance was assumed at P values of <0.05.3. Results and discussion
3.1. Sequence similarity
Comparison of human, mouse and hamster RFC1 with
rat MTX-1 revealed 66–67% amino acid identity between
human RFC1 on one, and RFC1 of mouse, hamster and rat
MTX-1 on the other side (Table 1). The percentage of se-
quence identity between the proteins from rat, mouse and
hamster was considerably higher, with values between 80%
and 90%. This relation strongly suggests that the rat MTX-1
is more closely related, from the phylogenetic view, to the
mouse and hamster RFC than these are to the human
carrier. This pattern also questions the distinction which has
been made between RFC1 and MTX-1 on the functional
level.Fig. 1. Alignment of the amino acid sequence of human RFC1, rat MTX-1
MegAlign v5.06 (DNAStar Inc.) according to the method of Hein with a ga
weighting according to the PAM250 table. Positions known to inﬂuence rfc f
an asterisk when not identical in all three proteins.Therefore, we further examined the amino acids at positions
which were known to be involved in protein functionality from
earlier analyses of human and mouse RFC1 mutants. How-
ever, of the 33 amino acids that have been identiﬁed as im-
portant for Mtx transport by RFC1 [14–19] only Ser 317 was
exchanged for an alanine in rat MTX-1 (Fig. 1). Replacement
of Ser 317 by the bulky amino acid phenylalanine was reported
to reduce the transport of Mtx more than 100-fold [17]. As Ser
317 is predicted to be localized within transmembrane domain
8, where it may form part of an aqueous channel, it appears
likely that replacement by phenylalanine would cause pore
blocking while an exchange with alanine should be of minor
signiﬁcance.
In accordance, the apparent aﬃnities of human and mouse
RFC1 and rat MTX-1 for Mtx that have been determined in
uptake studies are very similar. For human RFC1, Km or Kt
values (t for transport) between 3.15 and 5.1 lM were reported
in hRFC1 transfectants and leukemia cells expressing endog-
enous RFC1 [5,19,20]. For mouse RFC1, the Km=Kt values
were in essentially the same range 3.1–7.5 lM [15,16,18], while
they were only little higher for rat MTX-1: 23 lM in isolated
hepatocytes, 41 lM in transfected MDCK cells [10,12].and mouse RFC1. Multiple sequence alignment was performed using
p penalty of 11, a gap length penalty of 3, a Ktuple of 2 and residue
unction when mutated are shaded in gray and framed and marked with
Fig. 3. Inﬂuence of pH and sodium on RFC1 and MTX-1-mediated
FMTX uptake into Caco-2 and HPCT-1E3 cells. (# not signiﬁcant,
* P < 0:05, ** P < 0:01) Cells were seeded at a density of 50 000 (Caco-
2) or 15 000 (HPCT-1E3) per well and grown until they displayed a
diﬀerentiated phenotype. Medium was replaced with Tyrode salt so-
lution (137 mM NaCl, 3 mM KCl, 1 mMMgCl2, 2 mM CaCl2 and 5.5
mM glucose) buﬀered with 20 mM MES (pH 5.5) or 20 mM HEPES
(pH 7.5) or sodium free choline Tyrode salt solution. FMTX (10 lM)
was added after 15 min of equilibration and uptake over 30 min was
quantiﬁed by ﬂuorescence spectrophotometry (nP 6).
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HPCT-1E3 cells
So far, pH dependency of RFC1 and sodium dependency of
MTX-1 was thought to be a major functional criterion for the
distinction of the two proteins. We therefore compared the pH
dependency of FMTX uptake into human Caco-2 and rat
HPCT-1E3 cells. FMTX is an easily detectable marker sub-
strate of RFC1 and MTX-1 and the Caco-2 cells show an
enterocyte-like phenotype with high RFC1 expression [21],
while HPCT-1E3 cells are a good model for the study of rat
MTX-1 [10]. Although carriers of the OAT and human OATP
families are also known to transport FMTX and Mtx, its up-
take into Caco-2 and HPCT cells is dominated by RFC1 or rat
MTX-1, respectively, as a preliminary analysis showed. RT-
PCR detected no transcripts of OAT1-4 and OATP1B1, and
very low levels of OATP1B3 in Caco-2 cells, while RFC1 was
expressed strongly. In HPCT cells, OAT2 was found in addi-
tion to MTX-1. However, Mtx uptake in this cell type was
typically 60–95% sodium-dependent, which is not a property
of OAT-mediated uptake. Furthermore, OAT inhibition with
up to 1 mM salicylate never resulted in more than 25% re-
duction on FMTX uptake.
As depicted in Fig. 2, the human and the rat cell line showed
increased activity at acidic pH. In both cases, the level of
substrate uptake at pH 5.5 was approximately 3-fold higher
than at pH 7.5. Between pH 5.5 and 6.5, FMTX uptake into
Caco-2 showed a pronounced drop, while uptake into HPCT
decreased more gradually in the range between pH 5.5 and 7.5.
The observations conﬁrm the well established pH dependency
of human RFC1 and, for the ﬁrst time, demonstrate such a
dependency of rat MTX-1.
We further re-evaluated the sodium dependency of both
carriers at neutral and acidic pH (Fig. 3). Interestingly, this
uptake activity was clearly sodium-dependent at neutral pH,
but not at acidic pH (pH 5.5) in Caco-2 cells. The same ob-
servations were made using the rat cell line HPCT-1E3. WhileFig. 2. pH dependency of FMTX uptake into Caco-2 and HPCT-1E3
cells. Cells were seeded at a density of 50 000 (Caco-2) or 15 000
(HPCT-1E3) per well and grown until they displayed a diﬀerentiated
phenotype. Medium was replaced with Tyrode salt solution (137 mM
NaCl, 3 mM KCl, 1 mM MgCl2, 2 mM CaCl2 and 5.5 mM glucose)
buﬀered with 20 mM MES (pH 5.0–6.5) or 20 mM HEPES (pH 7.0–
8.0) and 10 lM FMTX was added after 15 min of equilibration. Up-
take was quantiﬁed after 30 min by ﬂuorescence spectrophotometry
(nP 6).the sodium dependency of rat MTX-1 at pH 7.5 is only a
conﬁrmation of previous knowledge, this is the ﬁrst report of
the inﬂuence of sodium on FMTX uptake by RFC1 in a hu-
man cell line. The mechanism behind this eﬀect of sodium on
FMTX uptake by RFC1 and MTX-1, as well as the reason for
the obviously diﬀerent situation at acidic pH remains a subject
of speculation. Possibly, a sodium-proton exchange may beFig. 4. Inhibition of MTX-1-mediated FMTX uptake into HPCT-1E3
cells by FA at pH 5.5. (* P < 0:05) HPCT cells were seeded at a density
of 15 000 per well and grown for 3 days until they displayed a diﬀer-
entiated phenotype. Medium was replaced with Tyrode salt solution
(137 mM NaCl, 3 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 5.5 mM
glucose and 20 mM MES, pH 5.5) containing increasing concentra-
tions of FA. FMTX (10 lM) was added after 15 min of equilibration
and uptake over 30 min was quantiﬁed by ﬂuorescence spectropho-
tometry (nP 6).
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OH gradient necessary to drive the transport process [22].3.3. FA inhibits FMTX uptake by rat MTX-1 at acidic pH
Previously, FA was not classiﬁed as inhibitor of rat MTX-1,
but known to decrease Mtx and FMTX uptake by the RFC. In
fact, incubation with 100 lM FA did not result in measurable
inhibition of Mtx uptake in rat liver hepatocytes at pH 7.4 [10],
while FA is a known substrate and inhibitor of RFC1 in cells
of non-hematopoietic origin, at least under acidic conditions
[8,9]. To resolve this apparent discrepancy, we tested the sen-
sitivity of FMTX uptake to FA at acidic pH in the MTX-1
expressing HPCT-1E3 rat hepatocytoma cells. As shown in
Fig. 4, there was a concentration-dependent and signiﬁcant
inhibition of MTX-1 activity at pH 5.5. Similar concentrations
(10 lM) did not have any eﬀect on FMTX uptake at neutral
pH in HPCT-1E3 cells nor in MDCK canine kidney cells that
were transfected with recombinant rat MTX-1 [12].
In conclusion, rat MTX-1 is more closely related to mouse
and hamster RFC1 than these are to human RFC1 on the
amino acid level. The only amino acid exchange at a sensitive
position was Ser317Ala. Although it remains unclear whether
this exchange is of similar signiﬁcance as the Ser317Phe tran-
sition that reduced the activity of mouse RFC1 more than 100-
fold, our functional comparison did so far not reveal a major
eﬀect. Furthermore, the apparent aﬃnities of human and
mouse RFC1 and ratMTX-1 forMtx are in the range 3–41 lM.
Finally, human RFC1 activity has now been recognized to be
sodium-dependent at neutral pH in a cellular context, as it was
known for MTX-1. Vice versa, rat MTX-1 activity is promoted
at acidic pH, where it is also sensitive to FA, as reported for
RFC1. On the basis of these ﬁve overlapping properties, we
suggest to regard MTX-1 as the rat ortholog of human RFC1.
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